[Federal Register Volume 85, Number 100 (Friday, May 22, 2020)]
[Notices]
[Page 31227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11077]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-645]


Bulk Manufacturer of Controlled Substances Application: Noramco, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 21, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on February 26, 2020, Noramco, Inc., 500 Swedes Landing 
Road, Wilmington, Delaware 19801-4417, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
Codeine-N-oxide........................     9053  I
Dihydromorphine........................     9145  I
Hydromorphinol.........................     9301  I
Morphine-N-oxide.......................     9307  I
Amphetamine............................     1100  II
Lisdexamfetamine.......................     1205  II
Methylphenidate........................     1724  II
Nabilone...............................     7379  II
Phenylacetone..........................     8501  II
Codeine................................     9050  II
Dihydrocodeine.........................     9120  II
Oxycodone..............................     9143  II
Hydromorphone..........................     9150  II
Hydrocodone............................     9193  II
Morphine...............................     9300  II
Oripavine..............................     9330  II
Thebaine...............................     9333  II
Opium extracts.........................     9610  II
Opium fluid extract....................     9620  II
Opium tincture.........................     9630  II
Opium, powdered........................     9639  II
Opium, granulated......................     9640  II
Oxymorphone............................     9652  II
Noroxymorphone.........................     9668  II
Tapentadol.............................     9780  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
as an Active Pharmaceutical Ingredient (API) for supply to its 
customers. In reference to drug codes 7360 (Marihuana) and 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture these 
drugs as synthetics. No other activities for these drug codes are 
authorized for this registration. This notice does not constitute an 
evaluation or determination of the merits of the company's application.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-11077 Filed 5-21-20; 8:45 am]
 BILLING CODE 4410-09-P